Previously: FDA, Public Citizen, and HIV policy research.
“Radical transparency” this isn’t. (2/2)
“Radical transparency” this isn’t. (2/2)
FDA today published complete response letters for 200 drugs, citing my research when I was at FDA. But they are only disclosing the CRLs for drugs that were subsequently approved – and these are already available on the FDA website. (1/2)
FDA today published complete response letters for 200 drugs, citing my research when I was at FDA. But they are only disclosing the CRLs for drugs that were subsequently approved – and these are already available on the FDA website. (1/2)